|By PR Newswire||
|March 27, 2014 10:40 AM EDT||
SALT LAKE CITY, March 27, 2014 /PRNewswire/ -- Numira, a leader in high resolution, 3D imaging services, visualization software, and cloud computing for the life science market, today announced the appointment of David Raminick as Vice President of Sales & Marketing.
"David's contributions and aptitude have proven invaluable and he embodies many of the wonderful traits of our organization," explains Hal Widlansky, CEO of Numira. "His innovative strategies and vision will continue to enhance our growth, build our client support services, and drive our profitability."
As VP, David brings over 20 years of sales, marketing, business development and finance experience to the Numira team. Prior to joining Numira, David served as VP of Business Development & Strategy for Radiate Media, a digital and broadcast media organization where he supplied strategic leadership and direction by driving relationship development, product roadmap, contract negotiation and execution of industry partnerships. These efforts resulted in accelerating product time to market by six months and tripling average per customer monthly revenue. Additionally, he had an extensive automotive tenure in the Volkswagen of America (VWoA) organization holding key management roles for Audi, Volkswagen Credit/Audi Financial Services and the Volkswagen brand. While at VWoA, he created and implemented a highly successful turnaround strategy for an underperforming Sales District; developed marketing/incentive programs resulting in previously unattained sales growth for the Audi Brand; and developed and managed $0.5B budget for Audi Brand.
David holds an M.B.A. from Wayne State University and a B.A. in Finance with Honor from Michigan State University.
"I'm thrilled to be joining the Numira team at this exciting time," exclaims Raminick. "There is phenomenal opportunity to not only continue to exceed existing client expectations, but also to develop new, long-term meaningful relationships and partnerships. I look forward to the continued development of our already industry-leading products, services and technology and to bringing new solutions to market that accelerate our clients' discovery efforts."
Numira is a specialized preclinical contract research organization (CRO) assisting pharmaceutical, biotech, and medical device companies to understand the efficacy of their products at the early stages of development. Utilizing patented imaging protocols and 3D quantitative analysis tools, Numira delivers images, metrics, and analyses that provide definitive results rapidly and accurately. Focused on therapeutic areas such as CNS, bone, pulmonary, oncology, and inflammation, Numira's novel customized solutions provide researchers with new insights and greater accuracy in a cost-effective and timely manner, helping to expedite the discovery process. For more information visit www.numira.com.